Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2005
12/22/2005US20050282150 Identifying an inhibitor of cyclin E2 polypeptide/cyclic-dependent kinase-2 complex formation by allowing a cyclin E2 polypeptide having a specific sequence and cdk2 to spontaneously associate to form a cyclin E2 polypeptide/cdk2 complex; adding test compound; and assaying for a decrease in complex
12/22/2005US20050281825 peptide transport proteins (PepTs); has antibody-dependent cell-mediated cytotoxic (ADCC) activity; cancer
12/22/2005US20050281819 Evolving new molecular function
12/22/2005US20050281815 CD40 splice variants and their uses
12/22/2005US20050281812 Antibodies to insulin-like growth factor I receptor
12/22/2005DE19605657B4 Menschliches Proinsulinderivat, Kodierende DNA, DNA enthaltender Expressionsvektor, mit diesem transformierter Mikroorganismus und Verwendung dieses menschlichen Proinsulinderivats Human proinsulin derivative-encoding DNA, DNA-containing expression vector, transformed with this microorganism and use of this human Proinsulinderivats
12/22/2005CA2573430A1 Anti-perp antibody
12/22/2005CA2567877A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
12/22/2005CA2566647A1 Inhibition of macrophage-stimulating protein receptor (ron)
12/22/2005CA2565888A1 Methods for transforming and expression screening of filamentous fungal cells with a dna library
12/21/2005EP1607402A1 Method for the diagnosis of tumour
12/21/2005EP1605890A1 Kit for pharmaceutical use
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1534754A4 Bi-specific antigen-binding compositions and related methods
12/21/2005EP1404852B1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter
12/21/2005EP1261625B1 Memno peptides, a process for their preparation and their use
12/21/2005EP1220934B1 Methods for making recombinant proteins using apoptosis inhibitors
12/21/2005EP1080182B1 Method of incorporating amino acid analogs using a hypertonic growth medium
12/21/2005EP0994947B1 Mu-1, member of the cytokine receptor family
12/21/2005EP0956338B1 Host cells and methods of producing proteins
12/21/2005EP0920524B1 A short-shafted adenoviral fiber and its use
12/21/2005EP0680331B1 Recombinant virus immunotherapy
12/21/2005CN1711283A Kit for assaying human low-molecular weight CD14 and antibody
12/21/2005CN1711018A Transgenic mammal carrying GANP gene transferred thereinto and utilization thereof
12/21/2005CN1710092A Method for extracting protein from yellow rice wine stillage
12/21/2005CN1710091A Method for increasing maize protein water solubility and degradation rate
12/21/2005CN1232649C Process of continuous production of casein bioactive polypeptide using integrally enzymolysis and filtering membrane
12/21/2005CN1232648C Method for producing antigen protein in use for hog cholera vaccine
12/21/2005CN1232641C Modulator for function of receptor of TNF/NGF receptor family and other protein
12/21/2005CN1232536C Human stem cell factor macrophage colony stimulating factor bifunction protein and its preparation
12/21/2005CN1232530C Ethene receptor protein of wheat and its coding sequence
12/21/2005CN1232304C Functional fragment antigen of tetanus toxin and tetanus vaccine
12/20/2005US6977293 Chimeric polypeptides
12/20/2005US6977174 Circular DNA molecule with conditional origin of replication, method for preparing the same and use thereof in gene therapy
12/20/2005US6977158 Mammalian IAP gene family, primers, probes, and detection methods
12/20/2005US6977154 Nucleic acid binding proteins
12/20/2005US6977150 Process and compositions for peptide, protein and peptidomimetic synthesis
12/20/2005US6977144 Nucleic acids encoding Selected Interacting Domain (SID registered) polypeptides binding selectively to a peptide encoded by a pathogenic strain of the hepatitis C virus; genetic engineering; gene therapy; bactericides;
12/20/2005US6977078 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
12/20/2005US6977072 Unblocking immunization at a regional lymph node by: promoting differentiation and maturation of immature dendritic cells in a regional lymph node and; allowing presentation by resulting mature dendritic cells of antigen to T-cells
12/20/2005US6977071 Use for treatment of inflammatory diseases, HIV-infection, angiogenisis and hematopoiesis-related disorders;
12/20/2005CA2266319C Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
12/20/2005CA1341491C Preparation of human igf and egf via recombinant dna technology
12/15/2005WO2005118864A2 Antibodies and related molecules that bind to psca proteins
12/15/2005WO2005118831A2 Polymeric compositions and related methods of use
12/15/2005WO2005118796A2 Reconstituted histone methyltransferase complex and methods of identifying modulators thereof
12/15/2005WO2005118619A1 Dipeptide exhibiting antihypertensive action
12/15/2005WO2005077093A3 Manufacture of highly phosphorylated lysosomal enzymes and uses thereof
12/15/2005WO2005038017A8 Prevention of incorporation of non-standard amino acids into protein
12/15/2005WO2005012359A3 Anti-vegf antibodies
12/15/2005WO2003062370A3 Multimeric proteins and methods of making and using same
12/15/2005WO2002083855A3 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/15/2005US20050277763 For cancer therapy
12/15/2005US20050277578 Immunity generation
12/15/2005US20050277199 Single-pass compound purification and analysis
12/15/2005US20050277176 Human and mouse beta-defensins, antimicrobial peptides
12/15/2005US20050277175 Truncated ADAMTS molecules
12/15/2005US20050277173 inoculating human lymphocytes, mitogens or polyclonal activators, to cultures and control cultures, then determining the degree of apoptosis and proliferation in the cultures; design of synthetic immunogens; screening of ligands that yield pharmacological effects
12/15/2005US20050277167 Prolyl 3-hydroxylases
12/15/2005US20050277153 detecting the presence or absence of nucleotide sequence variants in a sample to obtained from mammals, to determine if the mammal is predisposed to cardiovscular disorders or cancer; medical diagnosis
12/15/2005US20050277131 Mass spectrometry-based identification of proteins
12/15/2005US20050277127 High-throughput method of DNA immunogen preparation and immunization
12/15/2005US20050277123 Variants of NEDD4L associated with hypertension and viral budding
12/15/2005US20050276819 Helicobacter pylori CAI antigen
12/15/2005US20050276811 Natural IgM antibodies and inhibitors thereof
12/15/2005US20050276805 Antibody molecules having a Fc region with complex N-glycoside-linked sugar chains bound it through an N-acetylglucosamine of the reducing terminal of the sugar chains, which do not contain chains with a fucose bound to the N-acetylglucosamines.
12/15/2005US20050276801 Method of treatment using humanized anti-CD11a antibodies
12/15/2005CA2742088A1 Antibodies that bind psca proteins for diagnosis of cancer
12/15/2005CA2567449A1 Antibodies and related molecules that bind to psca proteins
12/15/2005CA2557330A1 Polymeric compositions and related methods of use
12/14/2005EP1605061A1 Neisseria genomic sequences and methods of their use
12/14/2005EP1605058A1 Method of screening light chain of antibdoy
12/14/2005EP1605057A2 Method for producing hyperglycosylated proteins
12/14/2005EP1605052A2 A method for producing influenza hemagglutinin multivalent vaccines
12/14/2005EP1605050A2 Morphological mutants of filamentous fungi
12/14/2005EP1605049A2 Fibrinolytically active polypeptide
12/14/2005EP1605046A1 Stably transfected cell lines expressing human GABA-A receptors with the subunit combination alpha-2, beta-3 and gamma-2
12/14/2005EP1605044A2 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker
12/14/2005EP1604015A1 METHOD FOR PRODUCING TARGET PROTEINS BY DELETING OR AMPLIFYING ibpA AND/OR ibpB GENE CODING FOR INCLUSION BODY-ASSOCIATED PROTEINS
12/14/2005EP1603590A2 Influenza virus vaccine
12/14/2005EP1603541A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
12/14/2005EP1603512A2 Novel cyclosporins
12/14/2005EP1534835A4 Hansenula polymorpha yapsin deficient mutant strain and process for the preparation of recombinant proteins using the same
12/14/2005EP1356060B1 Twin-arginine translocation in bacillus
12/14/2005EP1326895B1 Monoclonal antibodies directed against hepatitis b viruses
12/14/2005EP1280904B1 Pain signaling molecules
12/14/2005EP1263968B1 Beta 1, 2-xylosyltransferase-gene from arabidopsis
12/14/2005EP1177292B1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
12/14/2005EP1114160B1 Moraxella catarrhalis basb034 polypeptides and uses thereof
12/14/2005EP1007666B1 Neurturin receptor
12/14/2005EP0865486B1 Stable biotinylated biomolecule composition and methods
12/14/2005CN1706960A Feedback material-replenishing process of producing nisin
12/14/2005CN1231595C Process for prepn. naturally foled and secreted protein through co-secretion of molecular partner
12/14/2005CN1231594C Preparation method of natural folding and secreted protein
12/14/2005CN1231588C Morphological mutants of filamentous fungi
12/14/2005CN1231586C Polymorphic saccharomyces hansenii expression recombination cholere toxin B subunit gene and its application
12/14/2005CN1231583C Method for generating split, non-transferable genes that are able to express an active protein product
12/14/2005CN1231579C Process for producing trichodiene synzyme
12/14/2005CN1231497C Novel human protein with function for promoting mouse NIH/313 cell transformation and coding sequence thereof
12/14/2005CN1231496C Human protein with cancer cell growth suppressing function and its coding sequence
1 ... 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 ... 1125